DUSP6 and extranodal nasal NK/T cell lymphoma: In nasal-type natural killer/T-cell lymphoma (NKTCL), WTAP stabilizes DUSP6 mRNA and promotes DUSP6 protein expression, which results in cisplatin resistance [34].